Literature DB >> 1317827

Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia.

C P Felley1, H Kleiber, G D van Melle, P Frascarolo, E Jéquier, J P Felber.   

Abstract

The present study was designed to assess the respective effect of altered lipid metabolism and hyperglycemia on glucose metabolism in vivo in obese subjects. Six young obese non-diabetic volunteers were studied on four occasions during hyperinsulinemic clamp, twice during euglycemia and twice during hyperglycemia, with or without the infusion of beta-pyridylcarbinol, an inhibitor of lipid metabolism. Glucose oxidation was calculated from continuous respiratory exchange measurements, and glucose storage was obtained as the difference between total glucose disposal and glucose oxidation. Two-way analysis of variance (with interaction term) demonstrated (i) a significant increase for total glucose disposal with beta-pyridylcarbinol but no significant effect of hyperglycemia and no interaction between the two treatments, and (ii) an important increase of beta-pyridylcarbinol to enhance glucose storage but no significant effect of hyperglycemia and no interaction between the two treatments. These results show that obese people, at physiological insulinemia, enhance their glucose disposal and glucose storage when lipid oxidation is artificially lowered. This suggests that enhanced lipid oxidation is related to insulin resistance in these patients. However, hyperglycemia in these patients failed to compensate for defective glucose disposal or storage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317827

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  3 in total

Review 1.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

2.  Effect of lipid oxidation on the regulation of glucose utilization in obese patients.

Authors:  A Golay; J P Felber; D Jallut; R Munger; J Ruiz; E Jéquier
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

3.  An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.

Authors:  L J Baier; J C Sacchettini; W C Knowler; J Eads; G Paolisso; P A Tataranni; H Mochizuki; P H Bennett; C Bogardus; M Prochazka
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.